Global Adrenal Cancer Diagnostics Market – Industry Trends and Forecast to 2030

 Analyse et taille du marché du diagnostic du cancer de la glande surrénale

L’augmentation du nombre de cas de cancer dans le monde est l’un des principaux facteurs de croissance du secteur au cours de la période de prévision. En outre, les initiatives gouvernementales de soutien et la sensibilisation accrue devraient stimuler la croissance au cours de la période de prévision. Par exemple, l’administration Biden-Harris s’est fixé comme objectif de réduire la mortalité par cancer de 50 % au cours des 25 prochaines années et d’améliorer les connaissances des personnes vivant avec des tumeurs et y survivant.

Français Data Bridge Market Research analyse que le marché du diagnostic du cancer des surrénales, qui était de 130 milliards USD en 2022, devrait atteindre 207,20 milliards USD d'ici 2030, à un TCAC de 6 % au cours de la période de prévision 2023 à 2030. En plus des informations sur les scénarios de marché tels que la valeur marchande, le taux de croissance, la segmentation, la couverture géographique et les principaux acteurs, les rapports de marché organisés par Data Bridge Market Research comprennent également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché du diagnostic du cancer de la glande surrénale      

Market Definition

Adrenal cancer is a rare type that starts in one or both of the small, triangular glands (adrenal glands) on top of your kidneys. The adrenal glands produce hormones that instruct nearly every organ and tissue in your body. Adrenal cancer, also known as adrenocortical cancer, can strike anyone at any age. However, it is more likely to affect children under the age of five and adults in their 40s and 50s.

Global Adrenal Cancer Diagnostics Market Dynamics

Drivers

• Increasing incidence of adrenal cortical carcinoma

Increasing incidence of adrenal cortical carcinoma due to the spread of other types of cancer, advancement in imaging technologies to specifically identify adrenal cortical tumours, rising healthcare expenditure, and an increase in the number of cancer treatment centres globally are some of the dominant factors are fuelling the growth of the global adrenal cancer diagnostics market during the forecast period. For instance, Adrenal cortical carcinoma is a rare and aggressive cancer, according to the Journal of Clinical Endocrinology and Metabolism. Adrenal cortical carcinoma occurs at a rate of 0.7-2.0 cases per million people. Women are more likely to contract the disease. It is most commonly diagnosed between the ages of 40 and 50. These are the certain factors which propel the growth of the market.

• Rise in the geriatric population

According to GLOBOCAN, approximately 19.3 million new cancer cases were reported worldwide in 2020, with this figure expected to rise to 30.2 million new cases by 2040. According to the World Health Organization factsheet, cancer accounts for approximately one out of every six deaths worldwide. Cancer kills roughly 70% of people in low- and middle-income countries. The rise in the geriatric population and an increase in cancer cases are the major factors driving the growth of the adrenal cancer diagnostics market.

Opportunities

• Rising prevalence of cancer

Cancer is one of the leading causes of death worldwide, and its prevalence is increasing at an alarming rate. As a result, healthcare professionals are concentrating their efforts on the development of effective screening and treatment solutions to reduce prevalence levels. Early screening improves treatment regimen success rates. As a result, healthcare agencies and market players are promoting routine check-ups and screenings through various awareness programmes. For instance, in March 2022, HHS announced USD 5 million in funding to improve equity in cancer screening at health centres.

Restraints/Challenges

• Système d'imagerie diagnostique associé à un coût élevé

La demande croissante de tests de diagnostic du cancer, combinée aux avancées technologiques qui fournissent des résultats plus rapides et une plus grande précision, a fait grimper le coût des diagnostics du cancer de la glande surrénale. L'utilisation des diagnostics par imagerie dans l'industrie a augmenté de manière exponentielle au cours de la dernière décennie. Cependant, il a été observé dans plusieurs pays que plusieurs services de diagnostic du cancer ne sont pas entièrement couverts par l'assurance.

Le syndrome de Beckwith-Wiedemann est un trouble de la croissance caractérisé par un corps et des organes volumineux. Les personnes atteintes de ce syndrome présentent également un risque de cancer du rein et du foie.

Ce rapport sur le marché du diagnostic du cancer de la glande surrénale fournit des détails sur les nouveaux développements récents, les réglementations commerciales, l'analyse des importations et des exportations, l'analyse de la production, l'optimisation de la chaîne de valeur, la part de marché, l'impact des acteurs du marché national et local, les opportunités d'analyse en termes de poches de revenus émergentes, les changements dans la réglementation du marché, l'analyse stratégique de la croissance du marché, la taille du marché, la croissance du marché des catégories, les niches d'application et la domination, les approbations de produits, les lancements de produits, les expansions géographiques, les innovations technologiques sur le marché. Pour obtenir plus d'informations sur le marché du diagnostic du cancer de la glande surrénale, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à prendre une décision de marché éclairée pour atteindre la croissance du marché.

Impact du COVID-19 sur le marché du diagnostic du cancer de la glande surrénale

La pandémie de COVID-19 a eu un impact négatif sur les programmes de soins contre le cancer et sur le marché du cancer dans de nombreux pays. En outre, le début de la pandémie de COVID-19 a entravé les programmes de R&D impliquant le développement de produits et les essais cliniques axés sur le diagnostic du cancer. Les fabricants de dispositifs médicaux et les autres acteurs de la chaîne d'approvisionnement ont accordé une priorité élevée au développement et à la production de biens et d'accessoires liés au COVID-19.

Portée du marché mondial du diagnostic du cancer de la glande surrénale

Le marché du diagnostic du cancer de la glande surrénale est segmenté en fonction du type de tumeur , du traitement, du test et de l'utilisateur final. La croissance parmi ces segments vous aidera à analyser les segments de croissance faibles dans les industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.

Type de tumeur

• Phéochromocytome
• Carcinome corticosurrénalien
• Autres

Traitement

• Chirurgie
• Chimiothérapie
• Radiothérapie
• Thérapies ciblées contre le cancer
• Autres

 Test

• Imagerie par résonance magnétique (IRM)
• Tomodensitométrie (TDM)
• radiographie
• Tomographie par émission de positons (TEP)
• Biopsie

 Utilisateur final

• Hôpitaux
• Centres de chirurgie ambulatoire
• Centres de cancérologie
• Autres

Analyse/perspectives régionales du marché du diagnostic du cancer de la glande surrénale

Le marché du diagnostic du cancer des surrénales est analysé et des informations et tendances sur la taille du marché sont fournies par pays, type de tumeur , traitement, test et utilisateur final, comme référencé ci-dessus.

The countries covered in the adrenal cancer diagnostics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the adrenal cancer diagnostics market due to the availability of numerous bio-technology as well as medical device companies and high adoption of advanced technologies in this region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 owing to the availability of a large patient pool, skilled technicians at a comparatively lower price, and a defined regulatory framework favouring expedited product approvals in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The adrenal cancer diagnostics market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for adrenal cancer diagnostics market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the adrenal cancer diagnostics market. The data is available for historic period 2011-2021.

Competitive Landscape and Adrenal Cancer Diagnostics Market Share Analysis

The adrenal cancer diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to adrenal cancer diagnostics market.

Some of the major players operating in the adrenal cancer diagnostics market are:

• Annon Piezo Technology Co.,LIMITED. (China)
• APC International, Ltd. (U.S.)
• GSK plc (U.K.)
• F. Hoffmann-La Roche Ltd (Switzerland)
• Johnson & Johnson Services, Inc. (U.S.)
• AstraZeneca (U.K.)
• Siemens Healthcare GmbH (Germany)
• Bio-Rad Laboratories, Inc. (U.S.)
• Abbott (U.S.)
• TRS Technologies, Inc. (U.S.)
• Teledyne Defense Electronics (U.S.)
• TAIYO YUDEN CO., LTD. (Japan)
• Morgan Advanced Materials (U.K.)

Research Methodology: Global Adrenal Cancer Diagnostics Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report. 

SKU-56753